73 related articles for article (PubMed ID: 22776010)
1. Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men.
Angelova P; Momchilova A; Petkova D; Staneva G; Pankov R; Kamenov Z
Aging Male; 2012 Sep; 15(3):173-9. PubMed ID: 22776010
[TBL] [Abstract][Full Text] [Related]
2. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease.
Lausada NR; Boullón S; Boullón F; Tacconi de Gómez Dumm IN
Medicina (B Aires); 2007; 67(5):451-7. PubMed ID: 18051228
[TBL] [Abstract][Full Text] [Related]
5. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
6. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
7. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
[TBL] [Abstract][Full Text] [Related]
8. [Effect of etretinate treatment on fluidity and lipid composition of the erythrocyte membrane in patients with psoriasis].
Simonetti O; Messini L
G Ital Dermatol Venereol; 1989; 124(11-12):493-7. PubMed ID: 2638642
[TBL] [Abstract][Full Text] [Related]
9. Effect of hemodialysis on the content of fatty acids in monolayers of erythrocyte membranes in patients with chronic renal failure.
Dolegowska B; Kwiatkowska E; Wesolowska T; Bober J; Chlubek D; Ciechanowski K
Ren Fail; 2007; 29(4):447-52. PubMed ID: 17497467
[TBL] [Abstract][Full Text] [Related]
10. Changes in membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity.
Popp-Snijders C; Schouten JA; van Blitterswijk WJ; van der Veen EA
Biochim Biophys Acta; 1986 Jan; 854(1):31-7. PubMed ID: 3002462
[TBL] [Abstract][Full Text] [Related]
11. Changes in the fatty acid profiles of red blood cell membrane phospholipids in human neonates during the first month of life.
Pita ML; De Lucchi C; Faus MJ; Gil A
Clin Physiol Biochem; 1990; 8(2):91-100. PubMed ID: 2361356
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte membrane lipid composition fluidity in patients with essential hypertension.
Fu YF; Dong YZ; Li H; Lu ZM; Wang W
Chin Med J (Engl); 1992 Oct; 105(10):803-8. PubMed ID: 1291198
[TBL] [Abstract][Full Text] [Related]
14. Effect of lead on lipid peroxidation, phospholipids composition, and methylation in erythrocyte of human.
Shafiq-ur-Rehman
Biol Trace Elem Res; 2013 Sep; 154(3):433-9. PubMed ID: 23846836
[TBL] [Abstract][Full Text] [Related]
15. Effect of ethanol intake on human erythrocyte membrane fluidity and lipid composition.
Hrelia S; Lercker G; Biagi PL; Bordoni A; Stefanini F; Zunarelli P; Rossi CA
Biochem Int; 1986 May; 12(5):741-50. PubMed ID: 3729966
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
Leibowitz RL; Dorff TB; Tucker S; Symanowski J; Vogelzang NJ
BJU Int; 2010 May; 105(10):1397-401. PubMed ID: 19912179
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.
Sutipornpalangkul W; Morales NP; Unchern S; Sanvarinda Y; Chantharaksri U; Fucharoen S
J Med Assoc Thai; 2012 Jan; 95(1):29-36. PubMed ID: 22379738
[TBL] [Abstract][Full Text] [Related]
18. The membrane lipid and fatty acid composition of erythrocyte ghosts from three patients with paramyotonia congenita.
Marx A; Szymanska G; Melzner I; Rüdel R
Muscle Nerve; 1988 May; 11(5):471-7. PubMed ID: 3374519
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
20. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
